Current Report Filing (8-k)

Date : 11/12/2019 @ 9:05PM
Source : Edgar (US Regulatory)
Stock : Therapeutic Solutions International, Inc. (PC) (TSOI)
Quote : 0.0013  0.0002 (18.18%) @ 9:00PM

Current Report Filing (8-k)

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 12, 2019

 

THERAPEUTIC SOLUTONS INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada

 

000-54554

 

45-1226465

(State or other jurisdiction of

incorporation or organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification Number)

 

4093 Oceanside Boulevard, Suite B

Oceanside, California 92056

(Address of Principal Executive Offices and Zip Code)

 

(760) 295-7208

(Issuer's telephone number)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

.

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

.

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

On November 8, 2019 Mr. Timothy G. Dixon, the company CEO, entered into global settlement on monies owed to Mr. Dixon in the form of accrued payroll and a convertible note thereon totaling $534,714.68. Per the Agreement, Company will pay Mr. Dixon 0.5% of Net Sales (after COGS) of NanoStilbene *only* on a rolling 90 days to be paid out within 30 days of the close of previous 90-day period. Principal sum is frozen, and no further interest will be accrued. Missed payments are covered by an additional 30-day grace period and only that portion will accrue interest at a rate of 5% per annum. There are no other remedies other than stock conversion if a payment is missed. The promissory note is terminated.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

No.

 

Description

99.1

 

Mr. Dixon’s executed Agreement dated November 8, 2019


 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 12, 2019

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

 

By:

/s/ Timothy Dixon

 

Timothy Dixon

 

Chief Executive Officer

 

Therapeutic Solutions International, Inc. (PC) (USOTC:TSOI)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Therapeutic Solutions International, Inc. (PC) Charts.

Therapeutic Solutions International, Inc. (PC) (USOTC:TSOI)
Intraday Stock Chart

Today : Saturday 7 December 2019

Click Here for more Therapeutic Solutions International, Inc. (PC) Charts.

Latest TSOI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.